Investment of $55 million in Abu Dhabi's AppliedAI, spearheaded by G42, for the automation of back-office operations in rigidly regulated industries.
AppliedAI, a UK-origin AI startup now based in Abu Dhabi, has raised $55 million in a Series A funding round. This investment, led by G42, will be used to enhance the company's AI tools and expand its presence in the U.S. and Europe.
Founded by Arya Bolurfrushan, a former Goldman Sachs banker, AppliedAI focuses on automating back-office processes in regulated industries such as healthcare, insurance, and pharmaceuticals. The company's strategic location in Abu Dhabi, a growing hub for AI innovation and infrastructure, has played a significant role in its growth.
AppliedAI has already made a mark in the industry, processing over 4 million pages of U.S. medical records in the past year. Its AI-driven platform is designed for "high-cost-of-error workflows," ensuring accuracy where human lives may be on the line. This makes it a valuable asset in the complex medical billing records and insurance claims processes, outperforming traditional outsourcing firms like Cognizant and Wipro.
The startup's clientele includes Abu Dhabi's state-owned health group M42, American law firm Morgan & Morgan, and British drug safety monitoring company Qinecsa. With this new funding, AppliedAI aims to scale its AI research and development efforts, expand product offerings, and deepen its market presence in the Middle East and beyond.
Abu Dhabi's position as an AI hub, with major conferences like AI Everything Global 2026 attracting thousands of visitors and numerous startups, further fosters the AI ecosystem in which AppliedAI operates. The region's strong governmental and financial support for AI development, including partnerships with local initiatives and the availability of advanced AI data centers, has also contributed to AppliedAI's success.
The Series A funding values AppliedAI at $300 million pre-money, reflecting the potential of this innovative AI startup in the rapidly growing AI market. With its focus on automating critical processes in regulated industries and its commitment to accuracy, AppliedAI is well-positioned to make a significant impact in the AI landscape.
Investing in AppliedAI's technology will allow for the advancement of artificial-intelligence tools in the finance sector, as the company plans to scale its research and development efforts. By doing so, it aims to automate back-office processes in regulated industries, such as healthcare, insurance, and pharmaceuticals, which currently rely on complex medical billing records and insurance claims processes.
With the digital transformation sweeping across various industries, the integration of AI and investing holds immense potential. The increased funding for AppliedAI signifies a significant step towards realizing this potential, especially in the area of high-cost-of-error workflows, where AI-driven platforms, like AppliedAI's, can ensure accuracy and precision, potentially outperforming traditional firms in this domain.
